Understanding barriers to cervical cancer treatment for women with HIV in South Africa
Identifying and Addressing Barriers in the Cervical Cancer Treatment Cascade among Women with HIV in South Africa
This study is looking at the difficulties women with HIV in South Africa face when trying to get treatment for cervical cancer after abnormal Pap smear results, so we can find better ways to help them keep up with their care.
Quick facts
| Grant type | R21 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Boston University (Charles River Campus) NIH-funded |
| Lab location | 1 site (Boston, United States) |
| Project ID | NIH-10861288 on NIH RePORTER |
What this research studies
This research investigates the challenges faced by women living with HIV in South Africa regarding cervical cancer treatment. It focuses on identifying the specific barriers that prevent these women from attending follow-up appointments and receiving necessary care after abnormal Pap smear results. By understanding these obstacles, the research aims to develop tailored interventions that improve retention in the cervical cancer treatment cascade. The approach includes gathering data from various levels to create a comprehensive picture of the issues at hand.
Who could benefit from this research
Good fit: Ideal candidates for this research are women living with HIV in South Africa who have received high-risk abnormal Pap smear results.
Not a fit: Patients who are not living with HIV or who have not received abnormal Pap smear results may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to improved cervical cancer treatment outcomes for women with HIV, ultimately reducing mortality rates.
How similar studies have performed: Previous research has shown that addressing barriers to healthcare access can significantly improve patient outcomes, suggesting that this approach may be effective.
Where this research is happening
Boston, United States
- Boston University (Charles River Campus) — Boston, United States (Active)
Researchers
- Principal investigator: Stanton, Amelia M. — Boston University (Charles River Campus)
- Study coordinator: Stanton, Amelia M.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.